Updates on the diagnosis and treatment of prostate cancer.

about

Updates on the diagnosis and treatment of prostate cancer.

Item

http://www.wikidata.org/entity/Q47361793

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Updates on the diagnosis and treatment of prostate cancer.

@en

Updates on the diagnosis and treatment of prostate cancer.

@nl

type

Item

label

Updates on the diagnosis and treatment of prostate cancer.

@en

Updates on the diagnosis and treatment of prostate cancer.

@nl

prefLabel

Updates on the diagnosis and treatment of prostate cancer.

@en

Updates on the diagnosis and treatment of prostate cancer.

@nl

P1476

Updates on the diagnosis and treatment of prostate cancer.

@en

P2093

Anne Gasnier

http://www.w3.org/2001/XMLSchema#string

Nassim Parvizi

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality results from a randomized prostate-cancer screening trial

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2

Screening and prostate-cancer mortality in a randomized European study

METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer.

The role of focal therapy in the management of localised prostate cancer: a systematic review.

Prostate-specific antigen-based screening: controversy and guidelines

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.

The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinical

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

P304

20170180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1259/BJR.20170180

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

1075

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28555500

http://www.w3.org/2001/XMLSchema#string

P932

5594995

http://www.w3.org/2001/XMLSchema#string